Quidel | QDEL - Net Income


Quidel reported $-733M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bruker USD 26M 88.4M Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
Illumina USD 334M 184M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Neogen USD -17M 1.08M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -733M 477.6M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD 225.21M 76.29M Dec/2025